Patient centered experiences in breast cancer: Predicting long-term adherence to tamoxifen use

Medical Care

Volumn 45, Issue 5, 2007, Pages 431-439

  Kahn, Katherine L ^a,b   Schneider, Eric C ^c,d   Malin, Jennifer L ^e   Adams, John L ^a   Epstein, Arnold M ^c,d  

^a RAND CORPORATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e AMGEN INC   (United States)

Author keywords

Breast cancer; Long term adherence to tamoxifen; Patient centered care

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER STAGING; COHORT ANALYSIS; EPIDEMIOLOGY; FEMALE; HUMAN; MEDICAL AUDIT; MIDDLE AGED; PATIENT CARE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PROSPECTIVE STUDY; STATISTICS; TIME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HEALTH CARE SURVEYS; HUMANS; MEDICAL AUDIT; MIDDLE AGED; NEOPLASM STAGING; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PATIENT-CENTERED CARE; PROSPECTIVE STUDIES; TAMOXIFEN; TIME FACTORS; UNITED STATES;

EID: 34247354217     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000257193.10760.7f     Document Type: Article

References (40)

1. Institute of Medicine Committee on Quality of Health Care in America: Crossing The Quality Chasm: A New Health System For The 21st Century, Washington, DC: National Academy Press; 2001.
2. Davis K, Schoen C, Schoenbaum SC. A 2020 vision of American health care. Arch Intern Med. 2000;160:3357-3362.
3. Gerteis M, Edgman-Levitan S, Daley J, et al. Through the Patient's Eyes: Understanding and Promoting Patient-Centered Care. San Fran cisco, CA: Jossey-Bass; 1993.
4. Greenfield S, Kaplan S, Ware JE Jr. Expanding patient involvement in care. Effects on patient outcomes. Ann Intern Med. 1985;102:520-528.
5. Bartlett EE, Grayson M, Barker R, et al. The effects of physician communication skills on patient satisfaction, recall, and adherence. J Chronic Diseases. 1984;37:755-764.
6. Brody DS, Miller SM, Lerman CE, et al. Patient perception of involvement in medical care: relationship to illness attitudes and outcomes. J Gen Intern Med. 1989;4:506-511.
7. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med. 1993;153:1863-1868.
8. Kahn KL, Tisnado DM, Adams JL, et al. Does Ambulatory Process of Care Predict Health-related Quality of Life Outcomes? Health Services Research. Published online July 19, 2006 at http:www.blackwellsynergy.com/ toc/hesr/0/0. Accessed January 4, 2007.
9. Davis K, Schoenbaum SC, Audet A. A 2020 vision of patient-centered primary care. J Gen Intern Med. 2005;20:953-957.
10. Irwin RS, Richardson ND: Patient-focused care: using the right tools. Chest. 2006;130:738-828.
11. Little P, Everitt H, Williamson I, et al. Observational study of effect of patient centredness and positive approach on outcomes of general practice consultations. BMJ. 2001;323:908-911.
12. Stewart M, Brown JB, Donner A, et al. The impact of patient-centered care on outcomes. J Fam Pract. 2000;49:796-804.
13. Clark NM, Gong M, Schork MA, et al. Long-term effects of asthma education for physicians on patient satisfaction and use of health services. Eur Respir J. 2000;16:15-21.
14. Gordon K, Smith F, Dhillon S. Effective chronic disease management: patients' perspectives on medication related problems. Patient Educ Couns. 2007;65:407-415.
15. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: and overview of the randomised trials. Lancet. 1998;351:1451-1467.
16. Fisher B, Constantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371-1388.
17. Stewart HJ, Prescott RJ, Forrest AP. Scottish adjuvant tamoxifen trial: a randomized study updated to 15 years. J Natl Cancer Inst. 2001;93:456-462.
18. Delozier T, Spielmann M, Mace-Lesec'h J, et al. Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Federation Nationale des Centres de Lutte Contre le Cancer Breast Group. J Clin Oncol. 2000;18:3507-3512.
19. Swedish Breast Cancer Cooperative Group. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. J Natl Cancer Inst. 1996;88:1543-1549.
20. Sacco M, Valentini M, Belfiglio M, et al. Randomized trial of 2 versus 5 years of adjuvant tamoxifen for women aged 50 years or older with early breast cancer: Italian Interdisciplinary Group Cancer Evaluation Study of Adjuvant Treatment in Breast Cancer 01. J Clin Oncol. 2003;21:2276-2281.
21. Partridge AH, Wang PS, Winer EP, et al. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003;21:602-606.
22. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36:1138-1161.
23. Baum M, Buzdar A, Cuzick J, et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. Cancer. 2003;98:1802-1810.
24. Howell A, Cuzick J, Baum M, et al. Results of the ATAC (Arimidex, Tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet. 2005;365:60-62.
25. Schneider EC, Malin JL, Kahn KL, et al. Developing a national system to assess the quality of cancer care: ASCO's National Initiative on Cancer Care Quality. J Clin Oncol. 2004;22:2985-2991.
26. Malin IL, Schneider EC, Epstein AM, et al. Results of the National Initiative for Cancer Care Quality (NICCQ): How can we improve the quality of cancer care in the United States? J Clin Oncol. 2006;24:626-634.
27. Silliman RA, Guadagnoli E, Rakowski W, et al. Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol. 2002;20:2680-2688.
28. Miller NHY, Hill M, Kottke T, Ockene IS. Expert Panel on Compliance. The multi-level compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 1997;95: 1085-1090.
29. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
30. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38:303-312.
31. Kaplan SH, Greenfield S, Ware JE Jr. Assessing the effects of physicianpatient interactions on the outcomes of chronic disease. Med Care. 1989;27:s110-s127.
32. Liang W, Burnett CB, Rowland JH, et al. Communication between physicians and older women with localized breast cancer: Implications for treatment and patient satisfaction. J Clin Oncol. 2002;20:1008-1016.
33. Li JT, Sheeler RD, Offord KP, et al. Consultation for asthma: results of a generalist survey. Ann Allergy, Asthma Immunol. 1999;83:202-206.
34. Li CI, Malone KE, Weiss NS, et al. Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. J Natl Cancer Inst. 2001;93:1008-1013.
35. Fink AK, Gurwitz J, Rabowski W, et al. Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-posititve breast cancer. J Clin Oncol. 2004;22:3309-3315.
36. Powles T, Eeles R, Ashley S, et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet. 1998;352:98-101.
37. Mancuso CA, Charlson ME. Does recollection error threaten the validity of cross-sectional studies of effectiveness. Med Care. 1995;33(4 Suppl): AS77-AS88.
38. Coughlin SS. Recall bias in epidemiologic studies. J Clin Epidemiol. 1990;43:87-91.
39. Barsky AJ. Forgetting, fabricating, and telescoping: the instability of the medical history. Arch Intern Med. 2002;162:981-984.
40. Fisher D, Stewar AL, Bloch DA, et al. Capturing the patient's view of change as a clinical outcome measure. JAMA. 1999;282:1157-1163.